Comparative Systems Genetics of Cancer (R01)

The summary for the Comparative Systems Genetics of Cancer (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Comparative Systems Genetics of Cancer (R01): -Purpose. This NCI-sponsored Funding Opportunity Announcement (FOA) solicits grant applications for research projects focused on the development and application of comparative (cross-species) systems genetics approaches to address key cancer-relevant problems. The NCI requests applications for research projects that will use these approaches to enhance the understanding of the mechanisms that underlie: (i) human cancer susceptibility and (ii) heterogeneity of human tumors. The NCI expects that, to meet these goals, the proposed projects will involve appropriate interdisciplinary collaborations providing expertise in such areas as human genetics, statistical genetics, model organism genetics, systems biology, mathematical or computational modeling of biological processes, and computer sciences. The NCI requires that all projects propose to use two species, one of which must be human, and that the projects adhere to the cancer Biomedical Informatics Grid (caBIG ) standards. -Mechanism of Support. This FOA will utilize the NIH Research Project (R01) grant mechanism. -Funds Available and Anticipated Number of Awards. The NCI intends to commit approximately $3 million per year for up to five years to fund four to six individual multi-disciplinary research programs.
Federal Grant Title: Comparative Systems Genetics of Cancer (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-08-017
Type of Funding: Grant
CFDA Numbers: 93.39393.394
CFDA Descriptions: Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research
Current Application Deadline: No deadline provided
Original Application Deadline: May 14, 2008
Posted Date: Feb 21, 2008
Creation Date: Feb 21, 2008
Archive Date: Jun 14, 2008
Total Program Funding: $15,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.395 -- Cancer Treatment Research
Applicants Eligible for this Grant
Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K0...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) is not endorsed by, or affiliated with, any government agency. Copyright ©2019